Low altitude simulation without hypoxia improves left ventricular function after myocardial infarction by reducing...

Area of Science:

• Cardiovascular Physiology
• Altitude Medicine
• Myocardial Infarction Research

Background:

• Humans at lower elevations have reduced myocardial infarction (MI) mortality.
• Hypoxia from high altitudes (>5000 m) or simulated altitudes can reduce MI size in rodents.
• The role of non-hypoxic mechanisms in altitude-mediated cardioprotection requires further investigation.

Purpose of the Study:

• To investigate if altitude simulation below 2500 m reduces infarct size post-MI.
• To explore mechanisms beyond hypoxia, such as altered arterial function, in mediating these effects.

Main Methods:

• Mice underwent LAD ligation and recovered under simulated low altitude (714 mmHg) or control conditions (754 mmHg) for 1 week.
• Echocardiography assessed left ventricular function; left ventricular catheterization and ex-vivo mesenteric artery studies evaluated hemodynamic and vascular responses.
• HIF-1 activation and neovascularization were analyzed.

Main Results:

• Intermittent hypobaric treatment (simulated <2500 m) improved ejection fraction, cardiac output, stroke volume, and reduced infarct size.
• No changes in HIF-1 activation or neovascularization were observed.
• Acute low-altitude exposure reduced systemic vascular resistance and increased stroke volume and cardiac output, with enhanced arterial distensibility.

Conclusions:

• Intermittent hypobaric treatment at simulated altitudes <2500 m improves ventricular function and reduces infarct size post-MI.
• These cardioprotective effects are linked to improved arterial function, not hypoxia-induced neovascularization.